Engineering Animals to Grow Human Organs — But Not Human Minds

A chimera is an organism made up of cells from two or more different individuals. In this context, scientists are creating animal chimeras by engineering animals to grow human organs inside their bodies. This is done by injecting human stem cells into animal embryos, which then develop with a mix of animal and human cells. The goal is to produce organs like kidneys or livers that are compatible with human patients, reducing the risk of rejection during transplants. For example, in 2023, researchers successfully grew a human pancreas inside a pig embryo, though the organ was not fully developed. This technique relies on stem cells, which are cells that can turn into any type of cell in the body, and embryos, which are the earliest stage of development in an organism. The ethical and technical challenges of this approach are significant, as it requires precise control over cell development to ensure the organ functions correctly.

The primary motivation for engineering animal chimeras is to address the severe shortage of human organs available for transplantation. According to the Organ Procurement and Transplantation Network, over 100,000 people in the United States alone are on the waiting list for an organ transplant, and 17 people die each day while waiting. Animal chimeras could provide a renewable source of organs, potentially saving countless lives. Additionally, organs grown in animals might be less likely to be rejected by the human immune system because they are developed from the patient’s own stem cells. This approach could reduce or eliminate the need for lifelong immunosuppressant drugs, which have significant side effects. Researchers like Dr. Hiromitsu Nakauchi at Stanford University and the University of Tokyo have been at the forefront of this work, focusing on pigs as ideal candidates due to their similar organ sizes and lifespans to humans.

A major ethical concern in creating animal chimeras is the possibility that human cells could contribute to the development of the animal’s brain, raising questions about consciousness or suffering. To address this, scientists are taking steps to prevent human cells from populating the brain regions of the animal host. For instance, in experiments with pig embryos, researchers used genetic techniques to ensure that human stem cells were excluded from the part of the embryo that develops into the brain. This approach, sometimes called targeted exclusion, involves modifying the stem cells or the embryo itself to block human cells from contributing to neural tissues. The goal is to create organs without altering the animal’s cognitive functions or behavior, ensuring that the chimera remains fundamentally an animal and not a hybrid with human-like traits.

The creation and use of animal chimeras with human organs are subject to strict regulatory and ethical oversight. In the United States, agencies like the National Institutes of Health (NIH) and the Food and Drug Administration (FDA) have guidelines to ensure that such research is conducted responsibly. For example, the NIH has a moratorium on funding for certain types of chimera research, though it lifted a ban on growing human cells in animal embryos in 2019 under specific conditions. Ethical debates focus on the moral status of chimeras, the potential for unintended consequences, and the need for transparency in research. In 2021, Japan became the first country to allow the growth of human organs in animal embryos, provided that the resulting chimeras do not develop human-like brains. These regulations aim to balance scientific progress with ethical considerations.

As of 2026, researchers have made significant progress in growing human organs in animal chimeras, but major challenges remain. For example, in 2023, scientists reported growing a human kidney inside a pig, but the organ was only about 1% human cells, which is insufficient for transplantation. The biggest technical hurdle is ensuring that the human cells grow and function correctly within the animal host, while also preventing the organ from developing animal-specific traits that could cause rejection. Additionally, the efficiency of the process is low, with only a small percentage of injected stem cells successfully contributing to the organ. Ethical concerns about animal welfare and the potential for unintended consequences, such as the spread of human pathogens, also need to be addressed. Despite these challenges, the field is advancing rapidly, with ongoing experiments in countries like the United States, Japan, and China.